{
    "Trade/Device Name(s)": [
        "Sensititre HP susceptibility plate",
        "Sensititre 18-24 hour susceptibility plate",
        "Sensititre HP MIC Susceptibility Plate Telavancin 0.001-2ug/ml",
        "Sensititre 18-24 hour MIC Susceptibility System Susceptibility Test Panel for Telavancin 0.03-16ug/ml"
    ],
    "Submitter Information": "Trek Diagnostic Systems Inc.",
    "510(k) Number": "K093865",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY",
        "LRG"
    ],
    "Summary Letter Date": "February 17, 2010",
    "Summary Letter Received Date": "December 17, 2009",
    "Submission Date": "December 15, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Telavancin"
    ],
    "Specimen Type(s)": [
        "Fastidious isolates",
        "Non-fastidious isolates",
        "Gram-positive isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "In vitro antimicrobial susceptibility testing"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Plate",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for Sensititre HP and 18-24 hour susceptibility plates for in vitro antimicrobial susceptibility testing with Telavancin.",
    "Indications for Use Summary": "For in vitro susceptibility testing of fastidious isolates using Sensititre HP MIC plate and non-fastidious/Gram-positive isolates using Sensititre 18-24 hour MIC panel, with Telavancin dilution ranges.",
    "fda_folder": "Microbiology"
}